Clinical Trial Update: Effects of BCG on Immune Response [Phase 2, Phase 3]

View source ↗

Summary

Radboud University Medical Center completed Phase 2 and Phase 3 trials evaluating the effects of Bacillus Calmette-Guérin (BCG) on immune response in sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Sepsis | Phase 2, Phase 3 | Status: COMPLETED